165 related articles for article (PubMed ID: 3139442)
1. Effect of praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni.
el-Badrawy NM; Hassanein HI; Botros SS; Nagy FM; Abdallah NM; Herbage D
Exp Mol Pathol; 1988 Oct; 49(2):151-60. PubMed ID: 3139442
[TBL] [Abstract][Full Text] [Related]
2. Paeoniflorin targets apoptosis and ameliorates fibrosis in murine schistosomiasis mansoni: A novel insight.
Abd El-Aal NF; Hamza RS; Harb O
Exp Parasitol; 2017 Dec; 183():23-32. PubMed ID: 29037782
[TBL] [Abstract][Full Text] [Related]
3. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI
Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278
[TBL] [Abstract][Full Text] [Related]
4. Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis.
Morcos SH; Khayyal MT; Mansour MM; Saleh S; Ishak EA; Girgis NI; Dunn MA
Am J Trop Med Hyg; 1985 Mar; 34(2):314-21. PubMed ID: 3985273
[TBL] [Abstract][Full Text] [Related]
5. Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma-induced liver fibrosis.
Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; Megahed N
Parasitol Int; 2017 Oct; 66(5):545-554. PubMed ID: 28408356
[TBL] [Abstract][Full Text] [Related]
6. Effect of praziquantel on the distribution of interstitial collagen types I and III and basement membrane collagen types IV and V in murine hepatic schistosomiasis.
el-Badrawy NM; Abdel Hadi AM; Voss B; Metwally AA; Ebeid F
Trans R Soc Trop Med Hyg; 1991; 85(6):752-5. PubMed ID: 1801346
[TBL] [Abstract][Full Text] [Related]
7. Regression of hepatic lesions after treatment of Schistosoma mansoni or Schistosoma japonicum infection in mice: a comparative study.
Andrade ZA; Cox TM; Cheever AM
Am J Trop Med Hyg; 1993 Jul; 49(1):1-9. PubMed ID: 8352381
[TBL] [Abstract][Full Text] [Related]
8. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
Nessim NG; Demerdash Z
Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
[TBL] [Abstract][Full Text] [Related]
9. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203
[TBL] [Abstract][Full Text] [Related]
10. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
[TBL] [Abstract][Full Text] [Related]
11. Artichoke leaf extract protects liver of Schistosoma mansoni infected mice through modulation of hepatic stellate cells recruitment.
Sharaf El-Deen SA; Brakat RM; Mohamed ASED
Exp Parasitol; 2017 Jul; 178():51-59. PubMed ID: 28552793
[TBL] [Abstract][Full Text] [Related]
12. Effect of simultaneous and/or consecutive administration of the broad spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection.
William S; Guirguis F; Nessim NG
Arzneimittelforschung; 2003; 53(7):532-7. PubMed ID: 12918221
[TBL] [Abstract][Full Text] [Related]
13. Effect of combined chemotherapy and anti-inflammatory drugs on murine schistosomiasis.
Mahmoud MR; Zoheiry MM; Nosseir MM
Arzneimittelforschung; 2002; 52(4):294-301. PubMed ID: 12040972
[TBL] [Abstract][Full Text] [Related]
14. Histopathological evidences for the antifibrogenic effect of colchicine in schistosomiasis mansoni in mice.
Montasser MF; Younis TA; Fahmy IA; Sabry NM; el-Monayerhy MS; Rashad MS
J Egypt Soc Parasitol; 1994 Apr; 24(1):155-65. PubMed ID: 8169437
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis.
Chatterjee S; Vrolix G; Depoortere I; Peeters T; Van Marck E
BMC Infect Dis; 2005 Jun; 5():45. PubMed ID: 15949036
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice.
Ma Z; Liu X; Dong H; Xia D; Wang L; Chen Y; Xiong Y
Parasitol Res; 2018 Sep; 117(9):2831-2839. PubMed ID: 29946766
[TBL] [Abstract][Full Text] [Related]
17. Effect of praziquantel administration on hepatic stereology of mice infected with Schistosoma mansoni and fed a low-protein diet.
Barros LA; Costa-Silva M; Biolchini CL; Neves RH; Machado-Silva JR
Braz J Med Biol Res; 2009 Sep; 42(9):812-5. PubMed ID: 19738986
[TBL] [Abstract][Full Text] [Related]
18. Octreotide decreases connective tissue formation and improves vascular changes associated with hepatic schistosomiasis.
Mansy SS; Yehia HA; Hassan MM; Hassan EA; Youssef MM; Hadi AA; Mackenzie CD
J Egypt Soc Parasitol; 1998 Apr; 28(1):23-44. PubMed ID: 9617040
[TBL] [Abstract][Full Text] [Related]
19. Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice.
Said E; Said SA; Elkashef WF; Gameil NM; Ammar EM
Inflammopharmacology; 2012 Apr; 20(2):77-87. PubMed ID: 22278738
[TBL] [Abstract][Full Text] [Related]
20. The use of pentoxifylline as adjuvant therapy with praziquantel downregulates profibrogenic cytokines, collagen deposition and oxidative stress in experimental schistosomiasis mansoni.
El-Lakkany N; el-Din SS; Ebeid F
Exp Parasitol; 2011 Oct; 129(2):152-7. PubMed ID: 21762692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
